These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 17623988)

  • 1. Managing anemia. What do we do now? Views from Canada.
    Mendelssohn DC; Muirhead N; Manns BJ
    Nephrol News Issues; 2007 Jun; 21(7):55-7. PubMed ID: 17623988
    [No Abstract]   [Full Text] [Related]  

  • 2. The EPO/iron marriage: counseling needed.
    Bralow S
    Nephrol News Issues; 2007 Jun; 21(7):53, 55. PubMed ID: 17623987
    [No Abstract]   [Full Text] [Related]  

  • 3. Target hemoglobin level for EPO therapy in CKD.
    Parfrey PS
    Am J Kidney Dis; 2006 Jan; 47(1):171-3. PubMed ID: 16377399
    [No Abstract]   [Full Text] [Related]  

  • 4. Can evidence drive the development of a sound national EPO reimbursement policy?
    Wish JB
    Am J Kidney Dis; 2003 Jan; 41(1):254-8. PubMed ID: 12500246
    [No Abstract]   [Full Text] [Related]  

  • 5. ESA therapy for anemia management: a call for civil discourse.
    McAllister CJ
    Nephrol News Issues; 2007 Jun; 21(7):49-50. PubMed ID: 17623986
    [No Abstract]   [Full Text] [Related]  

  • 6. [Change of hemoglobin level: causes and consequences. Renal anemia].
    Ryckelynck JP
    Nephrol Ther; 2008 Oct; 4 Spec No 2():9-16. PubMed ID: 19000893
    [No Abstract]   [Full Text] [Related]  

  • 7. [Anemia in chronic renal failure and erythropoietin].
    Rosenlöf K
    Duodecim; 1995; 111(15):1489-95. PubMed ID: 9244705
    [No Abstract]   [Full Text] [Related]  

  • 8. To treat or not to treat renal anemia of chronic kidney disease patients?
    Tsubakihara Y
    Ther Apher Dial; 2010 Jun; 14(3):235-9. PubMed ID: 20609177
    [No Abstract]   [Full Text] [Related]  

  • 9. Continuous quality improvement (CQI) in rhu-Epo management: the outcome.
    Descamps C; Van Waeleghem JP; Ysebaert D
    EDTNA ERCA J; 1996; 22(3):22-6. PubMed ID: 10723328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. European best practice guidelines 1-4: evaluating anaemia and initiating treatment.
    Valderrábano F; Hörl WH; Jacobs C; Macdougall IC; Parrondo I; Cremers S; Abraham IL
    Nephrol Dial Transplant; 2000; 15 Suppl 4():8-14. PubMed ID: 11052144
    [No Abstract]   [Full Text] [Related]  

  • 11. European best practice guidelines 14-16: inadequate response to epoetin.
    Hörl WH; Jacobs C; Macdougall IC; Valderrábano F; Parrondo I; Thompson K; Carveth BG
    Nephrol Dial Transplant; 2000; 15 Suppl 4():43-50. PubMed ID: 11052148
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic guidelines for renal anemia in Japan].
    Naito M; Akiba T
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():562-5. PubMed ID: 15250369
    [No Abstract]   [Full Text] [Related]  

  • 13. European best practice guidelines 9-13: anaemia management.
    Jacobs C; Hörl WH; Macdougall IC; Valderrábano F; Parrondo I; Abraham IL; Segner A
    Nephrol Dial Transplant; 2000; 15 Suppl 4():33-42. PubMed ID: 11052147
    [No Abstract]   [Full Text] [Related]  

  • 14. Quality of life assessment in a recent haemoglobin trial in CKD (CHOIR).
    Kutner N
    Nephrol Dial Transplant; 2007 Jul; 22(7):2099. PubMed ID: 17395656
    [No Abstract]   [Full Text] [Related]  

  • 15. European best practice guidelines 6-8: assessing and optimizing iron stores.
    Macdougall IC; Hörl WH; Jacobs C; Valderrábano F; Parrondo I; Thompson K; Cremers S
    Nephrol Dial Transplant; 2000; 15 Suppl 4():20-32. PubMed ID: 11052146
    [No Abstract]   [Full Text] [Related]  

  • 16. The target hemoglobin in patients with chronic kidney disease.
    Singh AK
    Nephrol News Issues; 2006 Dec; 20(13):29-30. PubMed ID: 17168056
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical use of erythropoietin].
    Franchini M; Gandini G; Lippi G; De Gironcoli M; Cantini M; Aprili G
    Recenti Prog Med; 2004 Mar; 95(3):129-36; quiz 185. PubMed ID: 15143948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biological similarity of erythropoietin: controlled maturation].
    Combe C
    Nephrol Ther; 2009 Feb; 5 Spec No1():1-2. PubMed ID: 19233074
    [No Abstract]   [Full Text] [Related]  

  • 19. We are overreacting to our hemoglobin fear.
    Sadler JH
    Nephrol News Issues; 2007 Jun; 21(7):48. PubMed ID: 17623985
    [No Abstract]   [Full Text] [Related]  

  • 20. [Case of early pronounced anemia and its effective treatment with human recombinant erythropoietin in a female patient with polycystic kidney in a conservative stage of chronic renal failure].
    Alekseeva TB; Nikolaev AIu; Trofimova EI
    Ter Arkh; 1999; 71(6):70-1. PubMed ID: 10420463
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.